Invention Grant
- Patent Title: Arginase inhibitor combination therapies
-
Application No.: US15807357Application Date: 2017-11-08
-
Publication No.: US11291674B2Publication Date: 2022-04-05
- Inventor: Amani Makkouk , Matthew I. Gross , Francesco Parlati
- Applicant: CALITHERA BIOSCIENCES, INC.
- Applicant Address: US CA South San Francisco
- Assignee: CALITHERA BIOSCIENCES, INC.
- Current Assignee: CALITHERA BIOSCIENCES, INC.
- Current Assignee Address: US CA South San Francisco
- Agency: Fenwick & West LLP
- Agent Hugo Garrido; Carl Morales
- Main IPC: A61K31/69
- IPC: A61K31/69 ; A61K35/17 ; A61P35/00 ; A61K31/7076 ; A61K38/20 ; A61K31/4245 ; A61K31/675 ; A61K45/06 ; C12N5/0783
Abstract:
The disclosure relates to methods of treating or preventing a disease in a subject by conjointly administering to the subject an arginase inhibitor disclosed herein and a composition comprising immune cells disclosed herein.
Public/Granted literature
- US20180161349A1 ARGINASE INHIBITOR COMBINATION THERAPIES Public/Granted day:2018-06-14
Information query
